Blueprint Medicines Corp (BPMC) — Financial Flexibility Index
Blueprint Medicines Corp (BPMC) has a Financial Flexibility Index of -0.06x as of March 2025. Free cash flow of $-52.65 Million (operating CF $-54.48 Million minus capex $1.83 Million) represents 0% of total liabilities ($853.47 Million). Check BPMC strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Blueprint Medicines Corp Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Blueprint Medicines Corp across 12 annual periods. See BPMC working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Blueprint Medicines Corp (2013–2024)
Year-by-year free cash flow to debt coverage for Blueprint Medicines Corp. For the full company profile including market capitalisation, see Blueprint Medicines Corp stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.21x | $-187.96 Million | $-192.59 Million | $881.15 Million | ▲ +53.4% |
| 2023 | -0.46x | $-420.79 Million | $-436.85 Million | $918.64 Million | ▲ +22.5% |
| 2022 | -0.59x | $-493.36 Million | $-502.28 Million | $835.23 Million | ▼ -344.4% |
| 2021 | -0.13x | $-37.41 Million | $-298.65 Million | $281.49 Million | ▼ -108.5% |
| 2020 | 1.57x | $390.19 Million | $387.04 Million | $248.31 Million | ▲ +244.8% |
| 2019 | -1.08x | $-264.00 Million | $-278.01 Million | $243.34 Million | ▲ +19.1% |
| 2018 | -1.34x | $-162.33 Million | $-175.01 Million | $121.11 Million | ▼ -17.9% |
| 2017 | -1.14x | $-104.35 Million | $-119.86 Million | $91.77 Million | ▼ -257.8% |
| 2016 | -0.32x | $-22.16 Million | $-24.51 Million | $69.72 Million | ▲ +58.6% |
| 2015 | -0.77x | $-26.79 Million | $-31.68 Million | $34.92 Million | ▲ +67.9% |
| 2014 | -2.39x | $-34.70 Million | $-35.40 Million | $14.50 Million | ▲ +28.2% |
| 2013 | -3.33x | $-18.77 Million | $-19.02 Million | $5.63 Million | — |